Add BrightSurf on Google Email

University of Eastern Finland


Digital and group-based lifestyle counselling to prevent type 2 diabetes shows real-world effectiveness in Finnish health care

A one-year lifestyle intervention with a digital app and group counselling improved diet quality, reduced abdominal obesity and insulin resistance among 2907 Finnish adults at risk of type 2 diabetes. The study suggests that commitment to lifestyle counselling supports positive changes.

SourceUniversity of Eastern Finland·JournalThe Lancet Regional Health - Europe·DateOct 27, 2022

Adolescent arterial stiffness – a novel risk factor for hypertension and insulin resistance in young adulthood and for type 2 diabetes mellitus in mid-adulthood

Arterial stiffness in adolescence is a novel risk factor for hypertension, insulin resistance, and type 2 diabetes in young adulthood and mid-adulthood. Risk factors include maternal smoking habits, early life smoking patterns, high salt intake, genetic inheritance, obesity, and elevated blood pressure from childhood.

SourceUniversity of Eastern Finland·JournalJournal of Hypertension·DateJul 25, 2022

Pregnant women’s drinking correlates with their partner’s drinking

A new study found that pregnant women's use of alcohol correlates with that of their partner, highlighting the importance of both parents reducing their alcohol consumption. The research, which analyzed data from 14,822 Finnish women and their partners, showed that exposure to alcohol can have detrimental effects on fetal development.

SourceUniversity of Eastern Finland·JournalAlcoholism Clinical and Experimental Research·DateJun 8, 2022

Telemedicine helped ensure essential type 2 diabetes care amid the COVID-19 pandemic

A new study from University of Eastern Finland indicates that telemedicine played a crucial role in maintaining essential type 2 diabetes care amid the COVID-19 pandemic. Despite reduced face-to-face appointments, remote services for diabetes management cushioned the decline and kept overall contacts only 9% lower than 2019.

SourceUniversity of Eastern Finland·JournalBMC Health Services Research·DateJun 7, 2022

Disease-modifying antirheumatic drugs do not seem to protect people with rheumatoid arthritis against Parkinson’s disease

A new study found that disease-modifying antirheumatic drugs do not protect people with rheumatoid arthritis from developing Parkinson's disease. However, using chloroquine or hydroxychloroquine was associated with a lower risk of PD. The study controlled for various factors, including comorbidities and age.

SourceUniversity of Eastern Finland·JournalNeurology·DateJan 24, 2022